Top Companies in Organ Preservation Market | Key Players In-depth Analysis Research Report 2022-2028 by Vantage Market Research
Organ Preservation is the process of preserving an organ under controlled environmental conditions so that it can later be donated to hospitals or academic institutions for transplantation or research.
Coralia.Joe
Market Overview:
The Global Organ Preservation Market is valued at USD 206.1 Million in the year 2021 and is forecasted to reach a value of USD 297.7 Million by the year 2028. The Global Market is anticipated to grow to exhibit a Compound Annual Growth Rate (CAGR) of 6.3% over the forecast period. Organ Preservation is the process under which the organ is preserved in controlled environmental situations and later may be provided to hospitals or academic institutes for organ transplantation and research purposes. As per the current scenario, the liver, pancreas, and kidney can be successfully preserved for up to 2 days by flushing the organs and Organ Preservation solution and storing them at hypothermia (0–5°C). The solution is powerful as it makes use of some cell's impermeant agents (lactobionic acid, raffinose, and hydroxyethyl starch) that intercept the organs from swelling during cold ischemic storage.
The Organ Preservation Market in the denomination of preservation approach is classified into the perfusion system, gas mediators, and cold temperature. Among these, the cold temperature category is anticipated to be the highest proportion in the market. This is especially due to the cold treatment, along with cryopreservation, which preserves organs at −196°C for use, while few organs are stored at −4°C for a shorter duration of time.
Get Access to Our Free Sample Report: https://www.vantagemarketresearch.com/organ-preservation-market-1657/request-sample
Some of the key players operating in the Organ Preservation Market are listed below:
|
Company Name |
Revenue in the US |
|
<$5 Million |
|
$28 Million |
|
<$5 Million |
|
<$5 Million |
|
$28 Million |
|
<$5 Million |
|
<$5 Million |
|
<$5 Million |
|
<$5 Million |
|
<$5 Million |
Paragonix Technologies is a medical device company developing first-in-class Organ Preservation and Transport Systems for high-quality transplant organs. Its Sherpa Cardiac Transport System is a novel, single-use Organ Preservation device to standardize organ storage and improve donor organ quality. Paragonix Technologies has exclusively licensed intellectual property from the Board of Regents of The University of Texas. It was founded in 2010 and headquartered in Massachusetts, United States.
Xvivo Perfusion AB a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation in Sweden, the United States, North America, South America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers XVIVO System (XPS), an integrated off-the-shelf cardiac bypass system that includes various components needed to safely run normothermic ex vivo lung perfusion (EVLP); XPS Disposable Lung Kit that contains disposables and pre-packed products to suit the requirement for sterility; and STEEN Solution, a buffered extracellular solution optimally designed to perfuse the isolated donor lung during EVLP. The company was incorporated in 1998 and is headquartered in Gothenburg, Sweden.
Dr. Franz Koehler Chemie GmbH operates as a pharmaceutical company. The Company offers vascular protection solutions, therapeutics, X-ray contrast agents, and antidotes. Dr. Franz Koehler Chemie serves customers worldwide. It was founded in 1959 and it is headquartered in Germany.
Essential Pharmaceuticals, LLC was founded in 2006. The company's line of business includes the wholesale distribution of prescription drugs, proprietary drugs, and toiletries. The headquarters is in Durham.
TransMedics a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers an Organ Care System (OCS), portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor's hearts; and OCS Liver for the preservation of donor's livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
OrganOx Limited provides health care facilities. The Company offers a fully automated system for keeping a human donor liver functioning for up to 24 hours outside the body. OrganOx serves customers worldwide. It was founded in 2008 and it’s headquartered in the United Kingdom.
21st Century Medical was founded in 2002. The company's line of business includes the wholesale distribution of surgical and other medical instruments, apparatus, and equipment. The headquarters is in California.
Shanghai Genext Medical Technology Co., Ltd. operates as a medical device products and service provider in the field of organ transplantation. The Company provides Organ Preservation, transportation, evaluation, and repair, diagnostic reagents, and more. Shanghai Genext Medical Technology markets its products worldwide. It was founded in 2003 and it is headquartered in Shanghai.
Bridge to Life Ltd. distributes medical equipment. The Company supplies Organ Preservation solutions and perfusion technologies. Bridge to Life serves clients worldwide. It was founded in 2005 and it is headquartered in the United States.
Waters Medical Systems provides medical equipment. The Company offers a cold storage solution for kidney, liver, and pancreas, Organ Preservation, as well as renal perfusion equipment. It was founded in 1940 and it is headquartered in the Midwestern US.
Read Latest Blog Top Companies in Generic Drugs Market: https://v-mr.biz/generic-drugs-market
Do You Have Any Query or Specific Requirements? You may enquire to our sales team before purchase.
Contact us
Eric Kunz
6218 Georgia Avenue NW Ste 1 - 564
Washington DC 20011-5125
United States Tel: +1 202 380 9727
Email: [email protected]
Website: https://www.vantagemarketresearch.com/
Follow Us on LinkedIn: https://www.linkedin.com/company/vantage-market-research/
Follow Us on Twitter: https://twitter.com/vantagemarketr
